Effect of APC and Epo on the Inflammatory Response During Sepsis
Effect of Activated Protein C and Erythropoietin on the Microvascular Inflammatory Response During Severe Sepsis.
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Listed as NCT00229034, this observational or N/A phase trial focuses on Sepsis and Systemic Inflammation and remains completed. Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, it has been updated 9 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Jan 2025 — Apr 2025 [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Sep 2017 [monthly]
Unknown Status NA
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
For direct contact, visit the study record on ClinicalTrials.gov .